Clinical Trial Update: Comparison of Once Daily and Twice Daily Dosing on Safety and Tolerability of Memantine in Patients With Alzheimer [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing once daily versus twice daily memantine for safety and tolerability in Alzheimer dementia; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Alzheimer Dementia (AD) | Phase 4 | Status: COMPLETED | Results posted: 2019-03-14